Summit Life Science, Inc. (SLS) is an independent CRO (contract research organization) which is strong in Formulation R&D, Pilot Size Process Development, Phytochemical Screening, Regulatory Services and IP/Licensing. SLS has a state-of-the-art in house Innovation Center, where lead compounds screening and processing technologies are employed in various projects. SLS collaborates with many top university medical schools and research organizations, and can provide a full range of programs.
SEEDS "Self-Emulsified Drug Delivery System" is a cutting edge technology that converts poor water-soluble nutrients into nano sized particles. This methodology results in a product with 3 to 5 times higher bio-availability and absorption into the vital organs. for more information about SEDDS technology,
Stem cell technology is a rapidly developing field. By creating a cell model of medulloblastoma from human cells rather than working with mouse cells, SLS researchers can speed up screening of existing ingredients that might work against diseases.
Contract Research & Innovation Center & IP licensing
SLS DNA screening platform has over 8000 human blood samples, allowing the precise screening of various compounds before clinical studies. The human genome screening platform is one of the most advanced techniques and efficient ways for active compounds selection.